CKMT1B and hypopharynx cancer: Additionally, the burden of LoF in CKMT1B was associated with hypopharynx cancer (OR=1.03, p =3.9 × 10−26 ), vertiginous syndromes (OR=1.03, p=3.0× 10−17 ) and salivary glands cancer (OR=1.03; p=3.2× 10−12 ).